[go: up one dir, main page]

DE60012026D1 - Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien - Google Patents

Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien

Info

Publication number
DE60012026D1
DE60012026D1 DE60012026T DE60012026T DE60012026D1 DE 60012026 D1 DE60012026 D1 DE 60012026D1 DE 60012026 T DE60012026 T DE 60012026T DE 60012026 T DE60012026 T DE 60012026T DE 60012026 D1 DE60012026 D1 DE 60012026D1
Authority
DE
Germany
Prior art keywords
emu oil
microbial
topical application
therapeutic
emu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60012026T
Other languages
English (en)
Other versions
DE60012026T2 (de
Inventor
Sean Farmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ganeden Biotech Inc
Original Assignee
Ganeden Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ganeden Biotech Inc filed Critical Ganeden Biotech Inc
Publication of DE60012026D1 publication Critical patent/DE60012026D1/de
Application granted granted Critical
Publication of DE60012026T2 publication Critical patent/DE60012026T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60012026T 1999-08-26 2000-08-25 Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien Expired - Lifetime DE60012026T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US384043 1983-04-25
US38404399A 1999-08-26 1999-08-26
PCT/US2000/023448 WO2001013956A2 (en) 1999-08-26 2000-08-25 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications

Publications (2)

Publication Number Publication Date
DE60012026D1 true DE60012026D1 (de) 2004-08-12
DE60012026T2 DE60012026T2 (de) 2004-12-30

Family

ID=23515789

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60012026T Expired - Lifetime DE60012026T2 (de) 1999-08-26 2000-08-25 Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien

Country Status (8)

Country Link
US (5) US6531126B2 (de)
EP (1) EP1212093B1 (de)
JP (1) JP2003507437A (de)
AT (1) ATE270558T1 (de)
CA (1) CA2382670A1 (de)
DE (1) DE60012026T2 (de)
ES (1) ES2221624T3 (de)
WO (1) WO2001013956A2 (de)

Families Citing this family (161)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
ATE308987T1 (de) * 1997-04-18 2005-11-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
CA2382670A1 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
PE20010635A1 (es) * 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
SE518097C2 (sv) 2000-10-03 2002-08-27 Ellen Ab Förfarande för framställning av en absorberande sanitetsartikel som innefattar mjölksyraproducerande bakterier samt sådant alster
AU2002245181B2 (en) 2000-12-21 2006-06-29 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
US6528040B1 (en) * 2001-01-18 2003-03-04 Maurine Pearson EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
DK1560584T3 (da) * 2001-04-06 2009-05-18 Affinium Pharm Inc Fab I inhibitorer
IL142537A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of autoimmune diseases
US9101148B2 (en) * 2001-05-25 2015-08-11 Sbs Food Group Llc Carbohydrate modifying agent and drinks containing the modifying agent
US20090123606A1 (en) * 2001-05-25 2009-05-14 Frank Corsini Carbohydrate modifying agent and drinks containing the modifying agent
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US6878373B2 (en) * 2001-12-03 2005-04-12 Micropure Technologies, Inc. Probiotic composition containing Bacillus cereus RRRL B-30535
SE0104199L (sv) * 2001-12-13 2003-06-14 Sca Hygiene Prod Ab Ny produkt
US20030143262A1 (en) 2001-12-13 2003-07-31 Brusk Ulla Forsgren Hygiene tissue
AU2003226609A1 (en) * 2002-04-18 2003-10-27 Right After - Advanced Hygiene Solutions Ltd. A compound for cleansing the skin and a product impregnated therewith
US20060216267A1 (en) * 2002-08-20 2006-09-28 Kovacs Stephen G Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis
WO2004017903A2 (en) * 2002-08-20 2004-03-04 Pinnell Doren M Methods for treating fungal infections
US8404751B2 (en) * 2002-09-27 2013-03-26 Hallux, Inc. Subunguicide, and method for treating onychomycosis
US20070014743A1 (en) * 2002-09-27 2007-01-18 Birnbaum Jay E Subunguicide, and method for treating onychomycosis
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
EP1556009B2 (de) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Kosmetischer und pharmazeutischer schaum
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
DE10251301A1 (de) * 2002-11-03 2004-05-13 Roßmeier, Martin Lokal auf die Haut aufzutragendes Mittel
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
SE525647C2 (sv) * 2003-01-03 2005-03-29 Sca Hygiene Prod Ab Hygientissue för rengöring av och överföring av mjölksyraproducerande bakterier till huden och det urogenitila området
US7482023B2 (en) 2003-01-03 2009-01-27 Sca Hygiene Products Ab Hygiene tissue with lactic acid producing bacterial strains
WO2004067013A1 (en) * 2003-01-24 2004-08-12 Flora Technology Inc. Compositions and methods for restoring bacterial flora
CA2519429C (en) * 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US7033998B2 (en) 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7052715B2 (en) 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
SE526029C2 (sv) * 2003-05-13 2005-06-21 Sca Hygiene Prod Ab Hygien produkt innefattande bakteriepreparation och förfarande för dess framställning
SE526982C2 (sv) * 2003-05-27 2005-11-29 Sca Hygiene Prod Ab Enskiktspolymermatrisfilm innefattande mjölksyraproducerande bakterier, framställning samt användning därav
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2005026193A2 (en) * 2003-09-08 2005-03-24 United States Army Medical Research And Materiel Command Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof
EP2241326A1 (de) * 2003-12-08 2010-10-20 CPEX Pharmaceuticals, Inc. Pharmazeutische Zusammensetzungen und Verfahren zur Insulinbehandlung
US7029711B2 (en) * 2003-12-09 2006-04-18 Shannon Lynn Farrell Mixture of and method of making a trancutaneous pain relief composition
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
US7807622B2 (en) * 2004-04-23 2010-10-05 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
WO2006113925A2 (en) * 2005-04-20 2006-10-26 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
US7854927B2 (en) * 2004-05-11 2010-12-21 Ganeden Biotech, Inc. Methods and compositions for the dietary management of autoimmune disorders
US7374750B2 (en) * 2004-05-14 2008-05-20 Jennifer Albano Probiotic containing anhydrous hair care composition
KR101299399B1 (ko) 2004-06-04 2013-08-22 아피늄 파마슈티컬스, 인크. 치료제, 및 그의 제조 및 사용 방법
CN101065132A (zh) * 2004-07-28 2007-10-31 雷蒙德·M·普莱瓦 鸸鹋油和水果组合物
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060147423A1 (en) * 2004-12-07 2006-07-06 Jean-Yves Legendre Transungual device
US20060251593A1 (en) * 2005-04-07 2006-11-09 Work By Docs, Inc. Colored nail enamel treatment
CA2625818A1 (en) * 2005-04-20 2006-10-26 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
WO2006129149A2 (en) * 2005-05-31 2006-12-07 Wockhardt Limited Novel supplements for poultry and livestock
US20070009607A1 (en) * 2005-07-11 2007-01-11 George Jones Antibacterial/anti-infalmmatory composition and method
ATE503459T1 (de) * 2005-07-15 2011-04-15 Stefano Bardazzi Pharmazeutische zusammensetzung zur behandlung von xerostomie
US20070094893A1 (en) * 2005-09-02 2007-05-03 Veronica Flores Disposable flip-flop with exfoliating and moisturizing functions
EP1966229B1 (de) 2005-09-12 2015-10-21 Abela Pharmaceuticals, Inc. Systeme zur entfernung von dimethylsulfoxid (dmso) oder verwandten verbindungen, oder damit assoziierten gerüchen
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
EP1937286B1 (de) 2005-09-12 2016-03-09 Abela Pharmaceuticals, Inc. Zusammensetzungen aus dimethylsulfoxid (dmso)
US20080220103A1 (en) * 2005-10-24 2008-09-11 Jay Birnbaum Method for treating/controlling/killing fungi and bacteria on living animals
US20070116778A1 (en) * 2005-11-22 2007-05-24 Fierro Arthur A Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CN101389363A (zh) * 2005-12-22 2009-03-18 Sca卫生产品股份公司 吸收性制品
BRPI0520768A2 (pt) 2005-12-22 2009-05-26 Sca Hygiene Prod Ab artigo absorvente
JP5199551B2 (ja) * 2006-07-06 2013-05-15 サンスター株式会社 カンジダ菌感染に基づく疾患の予防又は改善剤
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
KR100806051B1 (ko) * 2006-09-06 2008-02-26 오교철 답손을 유효성분으로 함유하는 항진균용 약학 조성물
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
BRPI0622145A2 (pt) * 2006-11-17 2014-05-27 Sca Hygiene Prod Ab Artigo higiênico compreendendo uma composição inibidora de micróbio
BRPI0622146B1 (pt) * 2006-11-17 2016-08-23 Sca Hygiene Prod Ab tecido higiênico compreendendo uma composição inibidora de micróbio
AU2006350771B2 (en) * 2006-11-17 2012-12-06 Sca Hygiene Products Ab Lactobacillus fermentum Ess-1, DSM17851 and its use for the treatment and/or prevention of candidiasis and urinary tracrinfections
JP2010512865A (ja) * 2006-12-19 2010-04-30 フェロサン エーエス 乳酸菌を含む創傷または組織包帯
EP2125802A4 (de) * 2007-02-16 2014-08-20 Debiopharm Int Sa Salze, prodrugs und polymorphe von fab-i-inhibitoren
US20080255103A1 (en) * 2007-04-12 2008-10-16 Ballay Pharmaceuticals, Inc. Antihistamine and anti-nausea pharmaceutical compositions for topical application
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US20100136210A1 (en) * 2007-06-21 2010-06-03 Sca Hygiene Products Ab Sanitary article comprising lactobacilli in a hydrophilic carrier
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
SI2211626T1 (sl) 2007-08-29 2019-12-31 Ganeden Biotech, Inc. Pekovski izdelki
PT2638807T (pt) * 2007-10-16 2021-05-05 Ganeden Biotech Inc Composições de bebidas
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
US20090305387A1 (en) * 2008-01-30 2009-12-10 Ganeden Biotech, Inc. Compositions and methods for cleaning surfaces
WO2009106087A1 (fr) * 2008-02-25 2009-09-03 Kamel Belhocine Un medicament a usage dermique pour traiter les dermatophyties
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
US7788209B2 (en) * 2008-05-05 2010-08-31 United Technologies Corporation Hybrid fault reasoning and guided troubleshooting system that uses case-based reasoning and model-based reasoning
WO2010045541A1 (en) 2008-10-16 2010-04-22 Ganeden Biotech, Inc. Probiotic grain-based compositions
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
AU2010242955B2 (en) 2009-04-29 2016-02-04 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
WO2010128906A1 (en) * 2009-05-06 2010-11-11 Sca Hygiene Products Ab Sanitary article with probiotic effect
WO2011003062A2 (en) * 2009-07-03 2011-01-06 James Madison University Probiotic compositions and processes thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
BR112012010270A2 (pt) 2009-10-30 2016-11-29 Biogenic Innovations Llc mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco
JP5947721B2 (ja) 2009-10-30 2016-07-06 アベラ ファーマスーティカルズ インコーポレイテッド 変形性関節症を治療するためのジメチルスルホキシド（ｄｍｓｏ）およびメチルスルホニルメタン（ｍｓｍ）製剤
CA2780144A1 (en) * 2009-11-16 2011-05-19 Health Enhancement Products, Inc. Use of an extract derived from atcc #pta-5863 as an anti-inflammatory and anti-viral agent
EP2338476B1 (de) * 2009-12-02 2012-06-20 Bettina Heil Zäpfchen zur rektalen, vaginalen oder urethralen Verabreichung mit einem Probiotik, einem Antibiotikum und einer ungesättigten nicht-veresterten Fettsäure
US9486005B2 (en) 2010-02-22 2016-11-08 Smiti Vaid Gupta Agents and mechanisms for treating hypercholesterolemia
US9301982B2 (en) 2010-04-14 2016-04-05 Ganeden Biotech, Inc. Probiotic confection and lipid compositions
FR2967070B1 (fr) * 2010-11-05 2013-07-05 Oreal Acide gras monoinsature pour prevenir et/ou traiter les imperfections du teint de la peau
US8846740B2 (en) 2011-01-04 2014-09-30 Biological Responsibility, Llc Biotherapeutics for the treatment of infectious diseases
WO2012135499A1 (en) 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
US9138446B2 (en) 2011-06-08 2015-09-22 Scott Alan Weisenfluh EMU oil in combination with other active ingredients for treating skin imperfections
WO2013110077A1 (en) * 2012-01-19 2013-07-25 Hybrid Medical, Llc Topical therapeutic formulations
US10471131B2 (en) * 2012-01-19 2019-11-12 Hybrid Medical, Llc Topical therapeutic formulations
US20150044317A1 (en) * 2012-02-28 2015-02-12 Ganeden Biotech, Inc. Topical Compositions for Reducing Visible Signs of Aging and Methods of Use Thereof
WO2013130829A1 (en) * 2012-02-28 2013-09-06 Ganeden Biotech, Inc. Cosmetic compositions
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
US11224618B2 (en) 2012-04-16 2022-01-18 Zemtsov Enterprises, Llc Formulations and methods for treatment of acne and inflammatory skin conditions
WO2013185776A1 (en) 2012-06-12 2013-12-19 Ferrosan Medical Devices A/S Dry haemostatic composition
BR122021020778B1 (pt) 2012-06-19 2022-07-12 Debiopharm International Sa Derivados de pró-fármaco de (e)-n-metil-n-((3-metilbenzofuran-2-il) metil)-3-(7-oxo-5,6,7,8-tetraidro- 1, 8- naftirindin-3-il) acrilamida
EP2906946A1 (de) 2012-10-09 2015-08-19 The Procter & Gamble Company Verfahren zur identifikation oder bewertung nützlicher wirkstoffe und zusammensetzungen damit
JP6189962B2 (ja) 2012-10-09 2017-08-30 ザ プロクター アンド ギャンブル カンパニー 相乗作用する美容成分の組み合わせを特定する方法
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
EP2968886A1 (de) 2013-03-14 2016-01-20 Hallux, Inc. Verfahren zur behandlung von infektionen, krankheiten oder störungen der nägel
JP2016519064A (ja) 2013-03-14 2016-06-30 スリー イン ワン デンタル ピーエルエルシー３ ｉｎ １ Ｄｅｎｔａｌ ＰＬＬＣ 口腔乾燥症の治療及び歯の治療のための組成物
US10232028B2 (en) 2013-06-13 2019-03-19 Zivo Bioscience, Inc. Compounds and methods for affecting cytokines
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
US9596861B2 (en) 2013-12-24 2017-03-21 Sami Labs Limited Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
EP3258948B1 (de) 2015-02-16 2023-12-06 Zivo Bioscience, Inc. Anti-entzündliche und immunomodulatorische zusammensetzungen, enthaltend klebsormidium und verwendungen davon
EP3307871A2 (de) * 2015-06-11 2018-04-18 Biomimetx, S.A. Aus einer pseudomonas pf-11-kultur hergestellte antifouling-zusammensetzung
BR112017027695A2 (pt) 2015-07-03 2018-09-04 Ferrosan Medical Devices As seringa para retenção e mistura de primeira e segunda substâncias
EP3416501A4 (de) 2016-02-16 2019-11-20 Zivo Bioscience, Inc. Ernährungsunterstützung für tiere durch verabreichung eines aus algen gewonnenen nahrungsergänzungsmittels
SI3419628T1 (sl) 2016-02-26 2021-03-31 Debiopharm International Sa Zdravilo za zdravljenje infekcij diabetičnega stopala
BE1023643B1 (nl) 2016-03-21 2017-06-01 Yun NV Vaginale preparaten voor het onderhouden en / of herstellen van een gezonde vrouwelijke microbiota
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017240069B2 (en) 2016-03-31 2024-03-07 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
BE1024425B9 (nl) * 2016-06-21 2018-03-26 Yun NV Dermatologische preparaten voor het onderhouden en/of herstellen van een gezonde huidmicrobiota
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CA3043748A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2018157152A1 (en) * 2017-02-27 2018-08-30 Continuum Group Llc Sunscreen
US20180344627A1 (en) * 2017-06-06 2018-12-06 Muhammed Majeed Skin care applications of extracellular metabolites from bacillus coagulans
US11123382B2 (en) * 2017-06-06 2021-09-21 Sami Labs Limited Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
EP3801463A4 (de) * 2018-05-25 2022-05-04 Locus IP Company, LLC Therapeutische zusammensetzungen zur besseren heilung von wunden und narben
PH12021551922A1 (en) 2019-02-14 2022-05-23 Debiopharm Int Sa Afabicin formulation, method for making the same
MX2021012391A (es) 2019-04-09 2022-01-18 Dermbiont Inc Composiciones y metodos para mejorar la salud de la piel y para el tratamiento y la prevencion de enfermedades, trastornos y afecciones asociados con microbios patogenos.
CN114040770B (zh) * 2019-05-20 2025-02-28 莱雅公司 用于治疗、缓和或预防痤疮的组合物
UA129222C2 (uk) 2019-06-14 2025-02-12 Дебіофарм Інтернешнл С.А. Лікарський засіб і його застосування для лікування бактеріальних інфекцій, пов'язаних з біоплівкою
US11124438B2 (en) 2020-01-20 2021-09-21 Chio Kang Medical, Inc. Alcaligenes faecalis for degrading ethylene oxide
US11085016B1 (en) 2020-01-20 2021-08-10 Chio Kang Medical, Inc. Method for screening bacteria capable of degrading ethylene oxide
US11220667B2 (en) 2020-01-20 2022-01-11 Chio Kang Medical, Inc. Bacteria for degrading ethylene oxide and applications thereof
US11130939B2 (en) 2020-01-20 2021-09-28 Chio Kang Medical, Inc. Bacteria for degrading ethylene oxide and uses thereof
CN114573192B (zh) * 2022-03-28 2023-04-07 纪福林 一种污水及固废全域处理系统及其方法
DE202022001251U1 (de) 2022-05-11 2022-07-19 Pharmachem Pößneck GmbH & Co. KG Pharmazeutisches Hautpflegemittel

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062943A (en) 1974-11-20 1977-12-13 Board Of Supervisors Louisiana State University A & M Antibiotic produced from the microorganism (Pseudomonas lindbergii), its preparation and method of use
US4323651A (en) * 1974-12-04 1982-04-06 R. J. Reynolds Tobacco Company Thermostable lactase derived from bacillus
US4110477A (en) 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
US5413960A (en) 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
JPH01199575A (ja) * 1988-02-04 1989-08-10 Rikagaku Kenkyusho 新規なサイクロマルトデキストリン・グルカノトランスフェラーゼ及びその製造法
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
IT1227154B (it) 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
AT391323B (de) 1989-03-10 1990-09-25 Jungbunzlauer Ag Mikroorganismus der species bacillus coagulans sowie ein verfahren zur herstellung von optisch reiner l(+)-milchsaeure
JPH02255620A (ja) * 1989-03-28 1990-10-16 Kazuo Tsubaki 抗白癬菌剤およびその製造方法、利用方法
DE4001611C1 (de) * 1990-01-20 1991-02-28 Skw Trostberg Ag, 8223 Trostberg, De
US5200336A (en) * 1990-07-02 1993-04-06 New England Biolabs, Inc. Restriction endonuclease obtainable foam bacillus coagulans and a process for producing the same
US5431924A (en) 1990-11-14 1995-07-11 Emu Products Western Australia Pty. Ltd. Anti-inflammatory composition derived from emu oil
IT1262927B (it) 1992-01-14 1996-07-22 Consiglio Nazionale Ricerche Batteri sporgenti e loro impiego come probiotici
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
WO1994011492A1 (en) 1992-11-12 1994-05-26 Chr. Hansen's Laboratory, Inc. Method of favorably modifying poultry intestinal microflora
US6103246A (en) * 1993-06-03 2000-08-15 Tisdale; Carrie J. Creams and lotions containing emu oil
SE508881C2 (sv) * 1994-03-02 1998-11-16 Ctc Medical Ab Preparat avsett att vid behandling av i tänder befintliga amalgamfyllningar och/eller vid inserering av nya amalgamfyllningar hämma frisättning av Hg från amalgamet och/eller oskadliggöra frisatt Hg
US5472713A (en) * 1994-11-23 1995-12-05 Elf Resources, Inc. Therapeutic uses of emu oil
US5744128A (en) * 1995-05-03 1998-04-28 Holick; Michael F. Use of emu oil for stimulating skin and hair growth
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
US5939394A (en) * 1996-01-18 1999-08-17 Fleming & Company Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
US5698227A (en) * 1996-07-23 1997-12-16 Rivlin; Daniel Compositions comprising lidocaine and emu oil and methods of use thereof
AU6046198A (en) 1997-01-31 1998-08-25 Kenneth Hoyt Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ATE308987T1 (de) * 1997-04-18 2005-11-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US6399105B1 (en) * 1999-01-20 2002-06-04 Peter Donald Collin Sea cucumber carotenoid lipid fraction products and methods of use
CA2382670A1 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications

Also Published As

Publication number Publication date
US7048950B2 (en) 2006-05-23
US6531126B2 (en) 2003-03-11
DE60012026T2 (de) 2004-12-30
US7371407B2 (en) 2008-05-13
CA2382670A1 (en) 2001-03-01
WO2001013956A2 (en) 2001-03-01
US20040208860A1 (en) 2004-10-21
ATE270558T1 (de) 2004-07-15
ES2221624T3 (es) 2005-01-01
EP1212093B1 (de) 2004-07-07
WO2001013956A3 (en) 2001-10-04
US20030170334A1 (en) 2003-09-11
EP1212093A2 (de) 2002-06-12
JP2003507437A (ja) 2003-02-25
US20080274153A1 (en) 2008-11-06
US20060147544A1 (en) 2006-07-06
US20010033838A1 (en) 2001-10-25
US6733751B2 (en) 2004-05-11

Similar Documents

Publication Publication Date Title
DE60012026D1 (de) Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
CN100374099C (zh) 抗微生物组合物
Lam et al. Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns
US20040131567A1 (en) Antibacterial topical formulations
WO2001013927A3 (en) Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof
EP1049378B1 (de) Antimikrobielle zusammensetzung
BR0107241A (pt) Compostos, processo de preparação dos compostos, uso dos compostos, composições fungicidas, processo de combate preventivo ou curativo dos fungos fitopatogênicos das culturas e método de tratamento preventivo ou curativo da madeira de construção
DE59511002D1 (de) Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
ATE243042T1 (de) Biologisch aktive verbindungen aus ganoderma pfeifferi dms 13239
Morguette et al. The antibacterial and wound healing properties of natural products: A review on plant species with therapeutic potential against Staphylococcus aureus wound infections
ATE281150T1 (de) Mittel zur akne behandlung
ATE441423T1 (de) Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
DE59906392D1 (de) Hyaluronatlyase als penetrationsförderer in topischen mitteln
DE69511691D1 (de) Zusammensetzung und verfahren zur bekämpfung von pflanzenkrankheiten
SE9600716L (sv) Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
FI862609A0 (fi) Akne motverkande produkt.
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
EP1069898A4 (de) Topische antiseptische zusammenstellungen und methoden
DE102007030103A1 (de) Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel
CN110099567A (zh) 抗微生物昆虫驱避剂组合物
PT90085A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um complexo organico de ouro para aplicacao topica
EP1372603B1 (de) Topische zubereitung zur behandlung von zehennagelpilz
Maggi et al. The efficacy of 5% Sulfamylon® solution for the treatment of contaminated explanted human meshed skin grafts
SE8902124D0 (sv) Medel foer behandling aav herpesinfektioner
Wanigasekara et al. Antibacterial activity of a herbal deodorant formulated with Nymphaea pubescens flower petals against isolated human skin microflora

Legal Events

Date Code Title Description
8364 No opposition during term of opposition